In vitro effects of valproate and valproate metabolites on mitochondrial oxidations
- 1 June 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (11) , 2435-2442
- https://doi.org/10.1016/0006-2952(92)90324-c
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Inhibition by Valproic Acid of the Mitochondrial Oxidation of Monocarboxylic and ωHydroxymonocarboxylic Acids: Possible Implications for the Metabolism of Gamma-Aminobutyric Acid1The Journal of Biochemistry, 1987
- Valproic acid hepatic fatalitiesNeurology, 1987
- Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acidBiochemical and Biophysical Research Communications, 1985
- Inhibition of gluconeogenesis by sodium valproate and its metabolites in isolated rat hepatocytesXenobiotica, 1985
- Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoABiochemical Journal, 1983
- Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytesBiochemical and Biophysical Research Communications, 1983
- Influence of valproic acid on hepatic carbohydrate and lipid metabolismArchives of Biochemistry and Biophysics, 1983
- The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact ratsBiochemical Pharmacology, 1983
- Valproate–Induced Hepatic Injury: Analyses of 23 Fatal CasesHepatology, 1982
- Reye-like syndrome associated with valproic acid therapyThe Journal of Pediatrics, 1979